You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 251 No. 23, June 15, 1984 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs

A. R. Hinman and J. P. Koplan

Using recently published information, we examined the experience of a hypothetical cohort of 1 million children followed up from birth to 6 years of age without and with a pertussis vaccination program. Costs associated with death or lost wages were not estimated. A vaccination program reaching 90% of children would reduce disease incidence and disease-related costs by 90%. Taking into account costs associated with vaccine and vaccine reactions, the costs are reduced 82%. The ratio of overall costs without a program to those with a program is 5.7:1. The benefit-cost ratio is 11.1:1. Because we did not include indirect costs, this is a conservative estimate. Until improved vaccines are available, continued use of our present vaccines, with careful attention to possible contraindications, seems the only prudent course to follow.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Economic Evaluation of the 7-Vaccine Routine Childhood Immunization Schedule in the United States, 2001
Zhou et al.
Arch Pediatr Adolesc Med 2005;159:1136-1144.
ABSTRACT | FULL TEXT  

Responding to Parental Refusals of Immunization of Children
Diekema and and the Committee on Bioethics
Pediatrics 2005;115:1428-1431.
ABSTRACT | FULL TEXT  

Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies
Mattoo and Cherry
Clin. Microbiol. Rev. 2005;18:326-382.
ABSTRACT | FULL TEXT  

The Value of Prevention: Experiences of a Public Health Agency
Corso et al.
Med Decis Making 2002;22:S11-S16.
 

The Cost-effectiveness of Adolescent Hepatitis A Vaccination in States With the Highest Disease Rates
Jacobs et al.
Arch Pediatr Adolesc Med 2000;154:763-770.
ABSTRACT | FULL TEXT  

Economic Evaluation of Use of Diphtheria, Tetanus, and Acellular Pertussis Vaccine or Diphtheria, Tetanus, and Whole-Cell Pertussis Vaccine in the United States, 1997
Ekwueme et al.
Arch Pediatr Adolesc Med 2000;154:797-803.
ABSTRACT | FULL TEXT  

Gains in Life Expectancy from Medical Interventions -- Standardizing Data on Outcomes
Wright and Weinstein
NEJM 1998;339:380-386.
ABSTRACT | FULL TEXT  

The Association Between Adequacy of Prenatal Care Utilization and Subsequent Pediatric Care Utilization in the United States
Kogan et al.
Pediatrics 1998;102:25-30.
ABSTRACT | FULL TEXT  

Anemia and Elevated Lead Levels in Underimmunized Inner-city Children
Adams et al.
Pediatrics 1998;101 :e6-e6.
ABSTRACT | FULL TEXT  

Omission Bias and Pertussis Vaccination
Asch et al.
Med Decis Making 1994;14:118-123.
ABSTRACT  

Inadequate Immunizations: Identification Using Clinic Charts
Hymel et al.
CLIN PEDIATR 1993;32:156-160.
ABSTRACT  

Decision Analysis, Public Policy, and Pertussis: Are They Compatible?
Med Decis Making 1987;7:71-73.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.